NPPA Fixes Prices for 42 Drug Formulations Including Paracetamol, Atorvastatin Combos
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has fixed the retail prices of 42 drug formulations under the provisions of the Drugs (Prices Control) Order, 2013.
The authority issued the order on April 30, 2026, exercising powers conferred under paragraphs 5, 11 and 15 of the DPCO, 2013, read with relevant government notifications. The prices fixed are exclusive of Goods and Services Tax (GST), wherever applicable.
The list of formulations brought under price fixation includes commonly used combinations such as Aceclofenac, Paracetamol & Serratiopeptidase Tablets Manufactured and marketed by Pinnacle Life Science/ Softdeal Pharmaceutical, Albendazole & Ivermectin Tablets Manufactured and marketed by Theta Pharmaceuticals/ Aristo Laboratories, Cefixime & Potassium Clavulanate Tablets Manufactured and marketed by Purobien Lifesciences/ Unison Pharmaceuticals, Gliclazide & Metformin Hydrochloride Tablets Manufactured and marketed Alkem Health Science and many others.
The notice stated, "In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof"
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg (As enteric coated eq. to enzyme activity 30,000 units) | 1 Tablet | M/s Pinnacle Life Science Pvt. Ltd./ M/s Softdeal Pharmaceutica l Pvt. Ltd. | 10.18 |
2 | Acetylcysteine & Taurine Tablets | Each film coated tablet contains: Acetylcysteine USP 150 mg Taurine USP 500 mg | 1 Tablet | M/s Talent Healthcare/ M/s Zorvia Healthcare Ltd. | 14.72 |
3 | Albendazole & Ivermectin Tablets | Each uncoated chewable tablet contains: Albendazole IP 400 mg Ivermectin IP 6 mg | 1 Tablet | M/s Theta Pharmaceutica ls Ltd./ M/s Aristo Laboratories Pvt. Ltd. | 29.60 |
4 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg Ezetimibe IP 10mg | 1 Tablet | M/s East African (I) Overseas/ M/s Aristo Pharmaceutica ls Pvt. Ltd. | 21.36 |
5 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP | 1 Tablet | M/s East African (I) | 27.50 |
eq. to Atorvastatin 20mg Ezetimibe IP 10mg | Overseas/ M/s Aristo Pharmaceutica ls Pvt. Ltd. | ||||
6 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg Ezetimibe IP 10mg | 1 Tablet | M/s East African (I) Overseas/ M/s Aristo Pharmaceutica ls Pvt. Ltd. | 32.46 |
7 | Atorvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (as pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets) | 1 Capsule | M/s Safetab Life Science/ M/s Corona Remedies Ltd. | 15.36 |
8 | Atorvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets) | 1 Capsule | M/s Safetab Life Science/ M/s Corona Remedies Ltd. | 20.96 |
9 | Atorvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg (As green coloured spherical pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As two brown coloured film coated tablets Each containing 37.5 mg Clopidogrel Tablets IP) | 1 Capsule | M/s Windlas Biotech Ltd./ M/s Corona Remedies Ltd. | 30.48 |
10 | Cefixime & Potassium Clavulanate Tablets | Each film coated tablet contains: Cefixime (as Trihydrate) IP eq. to Anhydrous Cefixime 200 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 125 mg | 1 Tablet | M/s Purobien Lifesciences/ M/s Unison Pharmaceutica ls Pvt. Ltd. | 25.00 |
11 | Cefuroxime Axetil & Potassium Clavulanate Tablets | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 250 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg | 1 Tablet | M/s Associated Biopharma Pvt. Ltd./ M/s German Remedies Pharmaceutica ls Pvt. Ltd. | 38.35 |
12 | Cefuroxime Axetil & Potassium Clavulanate Tablets | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg | 1 Tablet | M/s Associated Biopharma Pvt. Ltd./ M/s German Remedies Pharmaceutica ls Pvt. Ltd. | 63.94 |
13 | Cefuroxime Axetil Tablets | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 250 mg | 1 Tablet | M/s Skymap Pharmaceutica ls Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 28.41 |
14 | Cefuroxime Axetil Tablets | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 250 mg | 1 Tablet | M/s Theon Pharmaceutica ls Ltd./ M/s Aristo | 29.42 |
Laboratories Pvt. Ltd. | |||||
15 | Clopidogrel, Aspirin & Atorvastatin Capsules | Each hard gelatin capsule contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg Aspirin IP 75mg (as Gastro-resistant tablet) Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (as film coated tablet) | 1 Capsule | M/s Safetab Life Science/ M/s Corona Remedies Ltd. | 6.19 |
16 | Clopidogrel, Aspirin & Atorvastatin Capsules | Each hard gelatin capsule contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg Aspirin IP 75 mg (as Gastro-Resistant Tablet) Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as film coated tablet) | 1 Capsule | M/s Safetab Life Science/ M/s Corona Remedies Ltd. | 8.80 |
17 | Etoricoxib & Paracetamol Tablets | Each film coated tablet contains: Etoricoxib IP 60 mg Paracetamol IP 325 mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd./ M/s German Remedies Pharmaceutica ls Pvt. Ltd. | 10.58 |
18 | Ferric Ammonium Citrate, Cyanocobalamin, Folic Acid, Cupric Sulphate & Manganese Sulphate Syrup | Each 15 ml (one tablespoonful) contains: Ferric Ammonium Citrate IP 160mg (eq. to Elemental Iron 32.8 mg) Cyanocobalamin IP 7.5 mcg Folic Acid IP 0.5 mg Cupric Sulphate USP 30 mcg Manganese Sulphate USP 30 mcg | 1 ml | M/s Crest Lifesciences Pvt. Ltd./ M/s Troikaa Pharmaceutica ls Ltd. | 0.88 |
19 | Gliclazide & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Gliclazide IP 80 mg Metformin Hydrochloride 500 mg | 1 Tablet | M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.)/ M/s Alkem Wellness Ltd. | 10.53 |
20 | Ivermectin & Albendazole Tablets | Each uncoated chewable tablet contains: Ivermectin IP 6 mg Albendazole IP 400 mg | 1 Tablet | M/s Ved Lifesavers (P) Ltd./ M/s Wockhardt Ltd. | 29.60 |
21 | Labetalol Hydrochloride Tablets | Each film coated tablet contains: Labetalol Hydrochloride IP 200 mg | 1 Tablet | M/s Samarth Life Sciences Pvt. Ltd. | 23.17 |
22 | L-Carnitine L-Tartrate, Methylcobalamin & Folic Acid Tablets | Each film coated tablet contains: L-Carnitine L-Tartrate eq. to L- Carnitine 500 mg Methylcobalamin IP 1500 mcg Folic Acid IP 1.5 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Glensmith Labs Pvt. Ltd. | 16.39 |
23 | Levosalbutamol & Ipratropium Bromide Respirator Solution | Each 2.5 ml contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 0.63 mg Ipratropium Bromide IP eq. to Ipratropium (Anhydrous) 500 mcg | 1 ml | M/s Axa Parenterals Ltd./ M/s Mankind Pharma Ltd. | 6.32 |
24 | Lobeglitazone Sulfate & Metformin Hydrochloride (Extended Release) Tablets | Each film coated bilayered tablet contains: Lobeglitazone Sulfate 0.5 mg Metformin Hydrochloride IP 500 mg (As Extended release) | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Zuventus Healthcare Ltd. | 10.34 |
25 | Lobeglitazone Sulfate & Metformin Hydrochloride (Extended Release) Tablets | Each film coated bilayered tablet contains: Lobeglitazone Sulfate 0.5 mg Metformin Hydrochloride IP 1000 mg (As Extended release) | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Zuventus Healthcare Ltd. | 11.99 |
26 | Methylprednisolone Tablets | Each uncoated tablet contains: Methylprednisolone IP 8 mg | 1 Tablet | M/s Foregen Healthcare Ltd./ M/s Zorvia Healthcare Ltd. | 6.00 |
27 | Metoprolol Succinate (Extended Release), Chlorthalidone & Telmisartan Tablets | Each film coated tablet contains: Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release) Chlorthalidone IP 12.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Primus Remedies Pvt. Ltd. | 11.99 |
28 | Metoprolol Succinate (Extended Release), Chlorthalidone & Telmisartan Tablets | Each film coated tablet contains: Metoprolol Succinate IP 47.50 mg eq. to Metoprolol Tartrate 50 mg (As extended-release) Chlorthalidone IP 12.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Primus Remedies Pvt. Ltd. | 14.44 |
29 | Olanzapine & Fluoxetine Tablets | Each film coated tablet contains: Olanzapine IP 5 mg Fluoxetine Hydrochloride IP eq. to Fluoxetine 20 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Cadila Pharmaceutica ls Ltd. | 10.64 |
30 | Olanzapine & Fluoxetine Tablets | Each film coated tablet contains: Olanzapine IP 10 mg Fluoxetine Hydrochloride IP eq. to Fluoxetine 20 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Cadila Pharmaceutica ls Ltd. | 13.40 |
31 | Paracetamol & Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 125 mg Mefenamic Acid IP 50 mg | 1 ml | M/s Foregen Healthcare Ltd./ M/s Zorvia Healthcare Ltd. | 0.79 |
32 | Paracetamol, Caffeine, Diphenhydramine Hydrochloride & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg Phenylephrine Hydrochloride IP 5 mg | 1 Tablet | M/s Unispeed Pharmaceutica ls Pvt. Ltd./ M/s Smart Laboratories Pvt. Ltd. | 4.52 |
33 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each film coated tablet contains: Relugolix 40 mg Estradiol Hemihydrate USP eq. to Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Macmillon Pharmaceutica ls Pvt. Ltd./ M/s Alembic Pharmaceutica ls Ltd. | 120.6 2 |
34 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each tablet contains: Relugolix 40 mg Estradiol Hemihydrate USP eq. to Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Macmillon Pharmaceutica ls Pvt. Ltd./ M/s Emcure Pharmaceutica ls Ltd. | 107.2 2 |
35 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each film coated tablet contains: Relugolix 40 mg Estradiol Hemihydrate USP eq. to Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Macmillon Pharmaceutica ls Pvt. Ltd./ M/s Jagsonpal Pharmaceutica ls Ltd. | 107.2 2 |
36 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each film coated tablet contains: Relugolix 40 mg Estradiol Hemihydrate USP eq. to Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Macmillon Pharmaceutica ls Pvt. Ltd./ M/s Aristo Pharmaceutica ls Pvt. Ltd. | 107.2 2 |
37 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each tablet contains: Relugolix 40 mg Estradiol Hemihydrate USP eq. to Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Macmillon Pharmaceutica ls Pvt. Ltd./ M/s Zydus Healthcare Ltd. | 116.0 0 |
38 | Relugolix, Estradiol & Norethindrone Acetate Tablets | Each film coated tablet contains: Relugolix 40 mg Estradiol Hemihydrate IP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Intas Pharmaceutica ls Ltd. | 110.0 0 |
39 | Telmisartan, Amlodipine & Hydrochlorothiazide Tablets | Each film coated tablet contains Telmisartan IP 40 mg Amlodipine Besilate IP eq. to Amlodipine 5 mg Hydrochlorothiazide IP 12.5 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Wellness Ltd. | 12.19 |
40 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol Tartrate 50 mg (As extended-release) | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Alkem Wellness Ltd. | 14.44 |
41 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release) | 1 Tablet | M/s Akums Drugs & Pharmaceutica ls Ltd./ M/s Alkem Wellness Ltd. | 11.99 |
42 | Vitamin D3 Oral Solution | Each 5 ml contains: Cholecalciferol IP 60000 IU (in Nano Droplet Form) | 1 ml | M/s Foregen Healthcare Ltd./ M/s Zorvia Healthcare Ltd. | 15.74 |
Further, the notification added,
The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.